Catégorie
Acalabrutinib
Numéro CAS
2412166-56-2
Formule moléculaire
C₃₀H₂₅N₇O₃
Masse moléculaire
531.58 g/mol
Synonyme

Benzamide, 4-[2-methyl-4-oxo-9-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]-4H-imidazo[5′,1′:3,4]pyrazino[1,2-a]pyrimidin-11-yl]-N-2-pyridinyl; 4-[2-Methyl-4-oxo-9-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]-4H-imidazo[5′,1′:3,4]pyrazino[1,2-a]pyrimidin-11-yl]-N-2-pyridinylbenzamide;2-Methyl-4-Oxo Acalabrutinib Impurity;

Mots-clés
Intermediates
Impurities
Metabolites.
Pharmaceutical Standards
Fine Chemicals
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Acalabrutinib Impurity 17 is a process-related impurity observed during the synthesis and analytical testing of Acalabrutinib. Monitoring this impurity is essential to ensure drug purity, evaluate stability, and understand potential degradation pathways, thereby maintaining the safety and efficacy of the final pharmaceutical product.